ResearchTechnology, Healthcare, Consumer Staples
WIA2020 | Rising Tech Stars 2020: Global & China's 100
Revenue and Net Profit of Wuxi Apptec Both Increased in 2020
Wuxi apptec said that the main reasons for the company's performance growth were the high growth of laboratories in China and the year-on-year growth of CDMO plate. China laboratory service is the core business of Wuxi apptec, accounting for more than 50% of its revenue. Its main business is small molecule drug discovery, drug analysis and testing.
Apr 01, 2021 04:39 PM
Evergrande's Financial Report 2020: High Growth, Scale Control, Debt Reduction
On the evening of March 31, China Evergrande released its 2020 annual report. According to the data, in 2020, China Evergrande's operating revenue was 507.248 billion yuan, a year-on-year increase of 6.2%; its net profit was 31.4 billion yuan, a year-on-year increase of 45.0%.
Apr 01, 2021 04:28 PM